We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000547:SZSEAddsino Co., Ltd. Analysis

Data as of 2026-06-13 - not real-time

CN¥20.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Addsino Co., Ltd. (000547.SZ) is trading at CNY 20.65, which is more than three times its discounted cash‑flow fair value of CNY 5.59, indicating a substantial valuation premium. The forward P/E of 50.4 far exceeds the industry average of 36.8, while the price‑to‑book ratio sits at 8.75, reinforcing the overvalued picture. On the earnings side the company posted a trailing EPS of –0.78 and a gross margin of –3.13%, with operating and net margins deeply negative, highlighting ongoing profitability challenges. Nevertheless, revenue has more than doubled year‑over‑year (growth factor 1.184) and cash flow remains positive, providing a modest cushion. The balance sheet shows a debt‑to‑equity of 19.6 and a debt level of CNY 0.88 bn against cash of CNY 1.53 bn, suggesting adequate liquidity.
Technically, the stock sits near its recent support of CNY 18.44 and below the resistance of CNY 26.11, with a neutral trend, an RSI of 41.8 and a bullish MACD crossover (histogram +0.014), while volume has been stable. However, 30‑day volatility is high at 62.8% and beta is only 0.63, implying the price can swing sharply without strong market correlation. Given the combination of an inflated valuation, persistent losses, and elevated price swings, a cautious stance is warranted. Investors may consider limiting exposure or waiting for a clearer earnings turnaround before adding positions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Neutral technical stance with bullish MACD crossover
  • Significant valuation premium
  • Stable trading volume

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent negative margins and earnings
  • DCF fair value far below market price
  • High price volatility

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Long‑term overvaluation relative to fundamentals
  • Ongoing profitability challenges in a defense‑sensitive sector
  • Geopolitical and regulatory uncertainties

Key Metrics & Analysis

Financial Health

Revenue Growth118.40%
Profit Margin-43.52%
P/E Ratio50.4
ROE-25.73%
ROA-4.51%
Debt/Equity19.62
P/B Ratio8.8
Op. Cash FlowCN¥301.3M
Free Cash FlowCN¥228.7M
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI41.8
SupportCN¥18.44
ResistanceCN¥26.11
MA 20CN¥21.45
MA 50CN¥24.56
MA 200CN¥20.30
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair ValueCN¥5.59
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.63
Volatility62.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.